Determining the true burden of kidney stone disease

被引:0
|
作者
Charat Thongprayoon
Amy E. Krambeck
Andrew D. Rule
机构
[1] Division of Nephrology and Hypertension,Department of Urology
[2] Mayo Clinic,undefined
[3] Indiana University,undefined
[4] Division of Epidemiology,undefined
[5] Mayo Clinic,undefined
来源
Nature Reviews Nephrology | 2020年 / 16卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The incidence and prevalence of kidney stones have increased over the past four decades. However, the diagnosis of ‘kidney stone’ can range from an incidental asymptomatic finding of limited clinical significance to multiple painful episodes of ureteral obstruction with eventual kidney failure. Some general strategies may be useful to prevent the recurrence of kidney stones. In particular, greater attention to kidney stone classification, approaches to assessing the risk of recurrence and individualized prevention strategies may improve the clinical care of stone formers. Although there have been some advances in approaches to predicting the recurrence of kidney stones, notable challenges remain. Studies of kidney stone prevalence, incidence and recurrence have reported inconsistent findings, in part because of the lack of a standardized stone classification system. A kidney stone classification system based on practical and clinically useful measures of stone disease may help to improve both the study and clinical care of stone formers. Any future kidney stone classification system should be aimed at distinguishing asymptomatic from symptomatic stones, clinically diagnosed symptomatic stone episodes from self-reported symptomatic stone episodes, symptomatic stone episodes that are confirmed from those that are suspected, symptomatic recurrence from radiographic recurrence (that is, with radiographic evidence of a new stone, stone growth or stone disappearance from presumed passage) and determine stone composition based on mutually exclusive categories.
引用
收藏
页码:736 / 746
页数:10
相关论文
共 50 条
  • [21] Proteornics and kidney stone disease
    Thongboonkerd, Visith
    PROTEOMICS IN NEPHROLOGY - TOWARDS CLINICAL APPLICATIONS, 2008, 160 : 142 - 158
  • [22] Kidney stone disease Preface
    Chi, Thomas
    Stoller, Marshall L.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2014, 3 (03) : 227 - 227
  • [23] Stone disease in kidney transplantation
    Yigit, B
    Aydin, Ç
    Titiz, I
    Berber, I
    Sinanoglu, O
    Altaca, G
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (01) : 187 - 189
  • [24] HLA AND KIDNEY STONE DISEASE
    SAFWENBERG, J
    BACKMAN, U
    DANIELSON, BG
    JOHANSSON, G
    LJUNGHALL, S
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1978, 12 (02): : 151 - 154
  • [25] MICRORADIOGRAPHY OF KIDNEY IN STONE DISEASE
    CARR, RJ
    CALCIFIED TISSUE RESEARCH, 1968, 2 (02): : 188 - &
  • [26] Chronic Kidney Disease in Kidney Stone Formers
    Rule, Andrew D.
    Krambeck, Amy E.
    Lieske, John C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (08): : 2069 - 2075
  • [27] What is the true burden of Clostridium difficile disease?
    Wren, M. W. D.
    Coen, P. G.
    Shetty, N. P.
    JOURNAL OF HOSPITAL INFECTION, 2007, 67 (02) : 196 - 197
  • [28] Monogenic Forms of Kidney Stone Disease in 800 adult Kidney Stone Formers from the Bern Kidney Stone Registry
    Anderegg, Manuel
    Olinger, Eric
    Schaller, Andre
    Taylor, Lea
    Bargagli, Matteo
    Geraghty, Rob
    Sayer, John A.
    Fuster, Daniel
    SWISS MEDICAL WEEKLY, 2022, 152 : 26S - 26S
  • [29] Monogenic Forms of Kidney Stone Disease in 841 Adult Kidney Stone Formers From the Bern Kidney Stone Registry
    Anderegg, Manuel A.
    Olinger, Eric G.
    Geraghty, Robert M.
    Schaller, Andre
    Bargagli, Matteo
    Pohlmeier, Lea
    Sayer, John A.
    Fuster, Daniel G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 761 - 761
  • [30] Understanding the true burden of dry eye disease
    Galor, Anat
    Levitt, Roy C.
    Felix, Elizabeth R.
    Sarantopoulos, Constantine D.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2015, 10 (05) : 403 - 405